期刊文献+

光动力学疗法净化造血干细胞的研究现状

PDT Using to Purify Hematopoietic Stem Cell:Current Research Status
下载PDF
导出
摘要 随着对光动力学疗法(photodynamic therapy,PDT)作用机制的深入研究和新型光敏剂的研发,PDT的应用已经拓展到多种肿瘤性疾病和非肿瘤性疾病的治疗,其中肿瘤性疾病包括皮肤癌、胃癌、食管癌等,而非肿瘤性疾病以鲜红癍痣、年龄相关性黄斑变性、痤疮等为代表。近年来,PDT行体外造血干细胞净化已成为PDT应用的另一新领域。实验证明PDT能够有效地杀灭多种肿瘤细胞,如白血病细胞、淋巴瘤细胞,且没有细胞周期特异性,对耐药肿瘤细胞同样有效,而对正常造血干细胞损伤轻微。目前应用PDT净化造血干细胞的试验与临床研究正成为国内外学者所关注的热点问题。 With the profound study of PDT mechanism and the new type of photosensitive drugs, the using of PDT has been expanded to many neoplastic diseases and nontumorous diseases. The neoplastic diseases include skin cancer, stomach cancer, esophageal carcino- ma and so on. The nontumorous diseases include port wine stains (PWS), age related macula degeneration, acne and others. In recent years, using PDT to purify hematopoietic stem cells (HSC) has become a new domain in application of PDT. Experi- ments have proved this method can kill many kinds of tumor cells effectively, such as leukemia and lymphadenoma without cell cycle specificity, and could be equally use to drug fast tumor cell with very little cell damage to the normal HSC. Now, the experimental and clinical research of using PDT to purify HSC has become the hot spot for the domestic and world scholars.
出处 《中国激光医学杂志》 CAS CSCD 2007年第5期325-328,共4页 Chinese Journal of Laser Medicine & Surgery
关键词 光动力学疗法 造血干细胞 自体造血干细胞移植 净化 Photodynamic therapy Hematopoietic stem cell Autologous hematopoietic stem cell transplantion Purification
  • 相关文献

参考文献7

二级参考文献40

  • 1高春记,楼方定,刘海川,姚善谦,汪月增.癌光啉加光照体外对白血病细胞的杀伤作用[J].中华血液学杂志,1994,15(7):370-370. 被引量:3
  • 2刘海川,姚善谦,楼方定,彭云,王连元,周绮,朱军,阎影,孟凡义,刘作斌,刘景汉,张伯龙.造血干细胞移植治疗白血病及其他恶性肿瘤112例临床研究[J].白血病,1996,5(2):70-73. 被引量:6
  • 3楼方定.稳步开展外周血干细胞移植工作[J].中华血液学杂志,1996,17(10):505-506. 被引量:14
  • 4[4]Steward A K, Imrie K, Eating A, et al. Optimizing the CD34 + Thy-1 + stem cell content of peripheral blood collections [ J ]. Exp Hematol, 1995, 23: 1619.
  • 5[5]Siena S, Bregni M, Brando B, et al. Flow cytometry for clinical estima tion of circulating hematopoietic progenitors for autologous tranplantation in cancer patients[J]. Blood, 1991, 77:400.
  • 6[6]Mayol A S, Vital J B, Llodra A G, et al. CD34+ cell dose and CD33 sudsets: collection and engraftment kinetics in autologous perioheral blood stem cells transplantation[J]. Haematologica, 1998; 83:48.
  • 7[7]Weaver C H, Hazelton B, Birch R, et al. An analysis of engraftment kinetics as a function of the CD34 + oontent of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy[J]. Blood, 1995, 86:3961.
  • 8[8]Fritsch G, Emminger W, Buchinger P, et al. CD34-positive cell progen itors in peripgeral blood correlate with colony-forming capacity[J ]. ExpHematol, 1991, 19: 1079.
  • 9[9]Welssman I V. Translating stem and progenitor cell biology to the clin ic: Barriers and opportunities[J]. Science, 2000; 287, 1442.
  • 10[10]Barnett D, Granger V, Storie I, et al. Quality assessment of CD34+ stem cell enumeration: experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation[J ]. Br J Haematol, 1998; 102: 553.

共引文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部